Laura Banov

Genoa, 16147, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Management of Severe Congenital Protein C Deficiency with Continuous Subcutaneous Infusion via Insulin Pump: A Pediatric Case Report.

Management of Severe Congenital Protein C Deficiency with Continuous Subcutaneous Infusion via Insulin Pump: A Pediatric Case Report.

Journal: Children (Basel, Switzerland)

Published: March 20, 2026

Safety and efficacy of direct oral anticoagulants in children with infection-related cerebral venous thrombosis: a real-life multicenter retrospective study.

Safety and efficacy of direct oral anticoagulants in children with infection-related cerebral venous thrombosis: a real-life multicenter retrospective study.

Journal: Thrombosis research

Published: January 23, 2026

Efanesoctocog Alfa Measurement on Stago Platforms: Can PTT-Automate Close the Gap?

Efanesoctocog Alfa Measurement on Stago Platforms: Can PTT-Automate Close the Gap?

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: November 10, 2025

Neonatal Presentation of Severe Hemophilia A: An Original Case Report and a Literature Review.

Neonatal Presentation of Severe Hemophilia A: An Original Case Report and a Literature Review.

Journal: Children (Basel, Switzerland)

Published: September 22, 2024

Real-world experience of rIX-FP prophylaxis at dosing intervals of 14 days or more in adult patients with haemophilia B in Italy - Results from IDEAL Part B.

Real-world experience of rIX-FP prophylaxis at dosing intervals of 14 days or more in adult patients with haemophilia B in Italy - Results from IDEAL Part B.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: February 23, 2024

Prolongated Activated Partial Thromboplastin Time (aPTT) in Pediatric Patients before Surgery-Crying Wolf: Lupus (Anticoagulant) Does Not Always Threaten Children.

Prolongated Activated Partial Thromboplastin Time (aPTT) in Pediatric Patients before Surgery-Crying Wolf: Lupus (Anticoagulant) Does Not Always Threaten Children.

Journal: Journal of clinical medicine

Published: January 19, 2024

Better Communication for Better Management of Persons with Hemophilia: Results from a Patients'-Clinicians' Project to Address the New Therapeutic Landscape.

Better Communication for Better Management of Persons with Hemophilia: Results from a Patients'-Clinicians' Project to Address the New Therapeutic Landscape.

Journal: Journal of clinical medicine

Published: November 20, 2023

Lupus Anticoagulant Detection under the Magnifying Glass.

Lupus Anticoagulant Detection under the Magnifying Glass.

Journal: Journal of clinical medicine

Published: September 06, 2023

Successful Multidisciplinary Management of Aortic Valve Repair in Severe Hemophilia B with Extended Half-Life Recombinant Factor IX Concentrate.

Successful Multidisciplinary Management of Aortic Valve Repair in Severe Hemophilia B with Extended Half-Life Recombinant Factor IX Concentrate.

Journal: Acta haematologica

Published: April 11, 2022

Hemophilia Care in the Pediatric Age.

Hemophilia Care in the Pediatric Age.

Journal: Journal of clinical medicine

Published: January 31, 2017

Recommendations for the use of long-term central venous catheter (CVC) in children with hemato-oncological disorders: management of CVC-related occlusion and CVC-related thrombosis. On behalf of the coagulation defects working group and the supportive therapy working group of the Italian Association of Pediatric Hematology and Oncology (AIEOP).

Recommendations for the use of long-term central venous catheter (CVC) in children with hemato-oncological disorders: management of CVC-related occlusion and CVC-related thrombosis. On behalf of the coagulation defects working group and the supportive therapy working group of the Italian Association of Pediatric Hematology and Oncology (AIEOP).

Journal: Annals of hematology

Published: April 29, 2015

Mycophenolate mofetil and Sirolimus as second or further line treatment in children with chronic refractory Primitive or Secondary Autoimmune Cytopenias: a single centre experience.

Mycophenolate mofetil and Sirolimus as second or further line treatment in children with chronic refractory Primitive or Secondary Autoimmune Cytopenias: a single centre experience.

Journal: British journal of haematology

Published: March 11, 2015

Showing 1-12 of 19

Last Updated: 09/26/2026